Product
Intrathecal Triple Therapy
3 clinical trials
5 indications
Indication
Acute Lymphoblastic LeukemiaIndication
T-cell Acute Lymphoblastic LeukemiaIndication
T-cell LymphomaIndication
Mixed Phenotype Acute LeukemiaIndication
Acute Myeloid LeukemiaClinical trial
Phase 1b/2 Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic LeukemiaStatus: Active (not recruiting), Estimated PCD: 2024-07-14
Clinical trial
SJALL23T: Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)Status: Not yet recruiting, Estimated PCD: 2027-12-01
Clinical trial
A Phase I and Expansion Cohort Study of Venetoclax in Combination With Chemotherapy in Pediatric Patients With Refractory or Relapsed Acute Myeloid LeukemiaStatus: Completed, Estimated PCD: 2020-10-27